Biopharmaceutical CMO Market Size, Share & Industry Analysis, By Service (Manufacturing {Upstream Processing and Downstream Processing}, Fill & Finish Operations, Analytical & QC Studies, and Packaging), By Source (Mammalian and Non-Mammalian), By Product (Biologics and Biosimilars), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 15.9% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Service

• Manufacturing




• Upstream Processing


• Downstream Processing




• Fill & Finish Operations


• Analytical & QC Studies


• Packaging

By Source

• Mammalian


• Non-mammalian

By Product

• Biologics


• Biosimilars

By Region

• North America (By Service, Source, Product, and Country)
  
  
  
  • U.S.
  
  
  • Canada
  
  
  
  


• Europe (By Service, Source, Product, and Country/Sub-Region)
  
  
  
  • Germany
  
  
  • U.K.
  
  
  • France
  
  
  • Italy
  
  
  • Spain
  
  
  • Scandinavia
  
  
  • Rest of Europe
  
  
  
  


• Asia Pacific (By Service, Source, Product, and Country/Sub-Region)
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • Southeast Asia
  
  
  • Rest of the Asia Pacific
  
  
  
  


• Latin America (By Service, Source, Product, and Country/Sub-Region)
  
  
  
  • Brazil
  
  
  • Mexico
  
  
  • Rest of Latin America
  
  
  
  


• Middle East & Africa (By Service, Source, Product, and Country/Sub-Region)
  
  
  
  • GCC
  
  
  • South Africa
  
  
  
  


• Rest of the Middle East & Africa